title: FOLFIRI with cetuximab or bevacizumab: FIRE-3-authors' reply.
authors.affiliation: Comprehensive Cancer Center Munich, Munich 81675, Germany. Electronic address: Volker.Heinemann@med.unimuenchen.de.
authors.forename: Volker
authors.initials: V
authors.lastname: Heinemann
authors.affiliation: Department of Hematology and Oncology, University of Munich, Munich, Germany.
authors.forename: Sebastian
authors.initials: S
authors.lastname: Stintzing
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002166:Camptothecin / Q000031:analogs & derivatives*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D005260:Female; D006801:Humans; D008297:Male
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D002166:Camptothecin